Počet záznamů: 1  

The Effect of Sulforaphane on Perinatal Hypoxic-Ischemic Brain Injury in Rats

  1. 1.
    SYSNO ASEP0560055
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevThe Effect of Sulforaphane on Perinatal Hypoxic-Ischemic Brain Injury in Rats
    Tvůrce(i) Kapoor, Sonam (FGU-C) ORCID
    Kala, David (FGU-C)
    Svoboda, Jan (FGU-C)
    Daněk, Jan (FGU-C)
    Faridová, Adéla (FGU-C) ORCID
    Brnoliaková, Z. (SK)
    Mikulecká, Anna (FGU-C) RID, ORCID
    Folbergrová, Jaroslava (FGU-C) RID
    Otáhal, Jakub (FGU-C) RID, ORCID, SAI
    Celkový počet autorů9
    Zdroj.dok.Physiological Research. - : Fyziologický ústav AV ČR, v. v. i. - ISSN 0862-8408
    Roč. 71, č. 3 (2022), s. 401-411
    Poč.str.11 s.
    Jazyk dok.eng - angličtina
    Země vyd.CZ - Česká republika
    Klíč. slovaperinatal hypoxic-ischemic insult ; rat ; FDG-PET ; sulforaphane ; neuronal damage ; motor impairment
    Obor OECDNeurosciences (including psychophysiology
    CEPGA18-07908S GA ČR - Grantová agentura ČR
    LM2018129 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    GA22-28265S GA ČR - Grantová agentura ČR
    Způsob publikováníOpen access
    Institucionální podporaFGU-C - RVO:67985823
    UT WOS000834626200006
    EID SCOPUS85135419620
    DOI10.33549/physiolres.934878
    AnotacePerinatal hypoxic-ischemic insult (HII) is one of the main devastating causes of morbidity and mortality in newborns. HII induces brain injury which evolves to neurological sequelae later in life. Hypothermia is the only therapeutic approach available capable of diminishing brain impairment after HII. Finding a novel therapeutic method to reduce the severity of brain injury and its consequences is critical in neonatology. The present paper aimed to evaluate the effect of sulforaphane (SFN) pre-treatment on glucose metabolism, neurodegeneration, and functional outcome at the acute, sub-acute, and sub-chronic time intervals in the experimental model of perinatal hypoxic-ischemic insult in rats. To estimate the effect of SFN on brain glucose uptake we have performed 18F-deoxyglucose (FDG) ??CT/PET. The activity of FDG was determined in the hippocampus and sensorimotor cortex. Neurodegeneration was assessed by histological analysis of Nissl-stained brain sections. To investigate functional outcomes a battery of behavioral tests was employed. We have shown that although SFN possesses a protective effect on glucose uptake in the ischemic hippocampus 24 h and 1 week after HII, no effect has been observed in the motor cortex. We have further shown that the ischemic hippocampal formation tends to be thinner in HIE and SFN treatment tends to reverse this pattern. We have observed subtle chronic movement deficit after HII detected by ladder rung walking test with no protective effect of SFN. SFN should be thus considered as a potent neuroprotective drug with the capability to interfere with pathophysiological processes triggered by perinatal hypoxic-ischemic insult.
    PracovištěFyziologický ústav
    KontaktLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Rok sběru2023
    Elektronická adresahttps://www.biomed.cas.cz/physiolres/pdf/2022/71_401.pdf
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.